Anticancer Research · 2019 · 23 citations · 38 references
PharmacyOncologyPharmacologyAntibody EngineeringCancer PharmacologyMolecular OncologyAntibody CharacterizationDiagnostic Antibody DesignTherapeutic Antibody DevelopmentTherapeutic Monoclonal AntibodiesTumor AntigensTumor-associated AntigensAntibody Binding SpecificityEnzymatic AssaysHuman Antibody LibrariesHumanized AntibodiesLung AdenocarcinomaMonoclonal Antibodies In CancerMonoclonal Antibodies In OncologySpheroid Culture
BACKGROUND/AIM: Carbonic anhydrase 12 (CA12) is a membrane-associated enzyme that is highly expressed on many human cancers. It is a poor prognostic marker and hence an attractive target for cancer therapy. This study aimed to develop a humanized CA12-antibody with anti-cancer activity. MATERIALS AND METHODS: Antibody libraries were constructed and screened by the Retrocyte display®. Antibody binding and blocking properties were determined by ELISA, flow cytometry and enzymatic activity assays. Spheroid viability was determined by Cell-Titer-Fluor assay. RESULTS: We developed a novel humanized CA12-specific antibody, 4AG4, which recognized CA12 as an antigen and blocked CA12 enzymatic activity. Our humanized CA12-antibody significantly inhibited spheroid growth of lung adenocarcinoma A549-cells in vitro by blocking CA12 enzymatic activity. Similar anti-tumor effects were recapitulated with CA12-gene knockout of A549-cells. CONCLUSION: Our newly identified humanized CA12-antibody with anti-cancer activity, represents a new tool for the treatment of CA12-positive tumors.
38
Proceedings of the National Academy of Sciences
2024 · 4.2K citations · Full text
Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Verónica Estrella, Tingan Chen, Mark C. Lloyd et al. · Cancer Research · 2013 · 1.4K citations · Full text
Medicine, Cancer Biology, Oncology +17
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Charles C. Wykoff, Nigel Beasley, Peter H. Watson et al. · PubMed · 2000 · 1.3K citations
Medicine, Cancer Biology, Oncology +17